Article Information
History
- June 23, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Youyi Fong1,2,
- Yunda Huang1,3,
- David Benkeser4,
- Lindsay N. Carpp1,
- Germán Áñez5,
- Wayne Woo5,
- Alice McGarry5,
- Lisa M. Dunkle5,
- Iksung Cho5,
- Christopher R. Houchens6,
- Karen Martins6,
- Lakshmi Jayashankar6,
- Flora Castellino6,
- Christos J. Petropoulos7,
- Andrew Leith8,
- Deanne Haugaard8,
- Bill Webb8,
- Yiwen Lu1,
- Chenchen Yu1,
- Bhavesh Borate1,
- Lars W. P. van der Laan1,9,
- Nima S. Hejazi1,10,
- April K. Randhawa1,
- Michele P. Andrasik1,
- James G. Kublin1,
- Julia Hutter11,
- Maryam Keshtkar-Jahromi11,
- Tatiana H. Beresnev11,
- Lawrence Corey1,12,
- Kathleen M. Neuzil13,
- Dean Follmann14,
- Julie A. Ake15,
- Cynthia L. Gay16,
- Karen L. Kotloff13,
- Richard A. Koup17,#,
- Ruben O. Donis6,#,
- Peter B. Gilbert1,2,18,*,#,
- the Immune Assays Team§,
- the Coronavirus Vaccine Prevention Network (CoVPN)/2019nCoV-301 Principal Investigators and Study Team§,
- the United States Government (USG)/CoVPN Biostatistics Team§
- 1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
- 2Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
- 3Department of Global Health, University of Washington; Seattle, WA 98195, USA.
- 4Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
- 5Novavax, Inc., Gaithersburg, MD, USA.
- 6Biomedical Advanced Research and Development Authority, Washington, DC, USA.
- 7LabCorp-Monogram Biosciences, South San Francisco, CA, USA.
- 8Nexelis, Seattle, WA, USA.
- 9Department of Statistics, University of Washington, Seattle, WA, USA.
- 10Department of Biostatistics, T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
- 11Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Rockville, MD, USA
- 12Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
- 13Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
- 14Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
- 15U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
- 16University of North Carolina School of Medicine, Chapel Hill, NC, USA.
- 17Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
- 18Department of Biostatistics, School of Public Health, University of Washington, Seattle, WA, USA.
- ↵*Corresponding author. pgilbert{at}fredhutch.org
↵# These authors contributed equally to this work.